Top experts by indication / Oncology
Most active experts in Melanoma
2026 edition, data as of October 26, 2026
458 key opinion leaders in the directory are tagged to Melanoma. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 258 of the 458 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Craig SlingluffUniversity of Virginia School of Medicine, VA | 33 trials |
| 2 | Ahmad TarhiniMoffitt Cancer Center, PA | 20 trials |
| 3 | Svetomir MarkovicMayo Clinic, MN | 20 trials |
| 4 | Diwakar DavarUPMC Hillman Cancer Center, PA | 13 trials |
| 5 | Thomas GajewskiUniversity of Chicago, IL | 11 trials |
| 6 | Adil DaudUniversity of California, San Francisco, FL | 11 trials |
| 7 | Nikhil KhushalaniMoffitt Cancer Center, NY | 11 trials |
| 8 | Agop BedikianThe University of Texas MD Anderson Cancer Center, TX | 10 trials |
| 9 | Sapna PatelCO | 10 trials |
| 10 | Brendan CurtiProvidence Cancer Institute, OR | 9 trials |
| 11 | Harriet KlugerYale School of Medicine, CT | 9 trials |
| 12 | Cassian YeeThe University of Texas MD Anderson Cancer Center, TX | 9 trials |
| 13 | Jedd WolchokWeill Cornell Medicine, NY | 8 trials |
| 14 | Wen-Jen HwuTX | 7 trials |
| 15 | Zeynep ErogluFL | 7 trials |
| 16 | William CarsonThe Ohio State University, OH | 7 trials |
| 17 | Janice MehnertNYU Langone Health, NY | 7 trials |
| 18 | Ravi AmaravadiUniversity of Pennsylvania, PA | 7 trials |
| 19 | Matthew BlockMN | 6 trials |
| 20 | David HongThe University of Texas MD Anderson Cancer Center, TX | 6 trials |
| 21 | Elizabeth BuchbinderDana-Farber Cancer Institute, MA | 6 trials |
| 22 | Frank HodiDana-Farber Cancer Institute, MA | 6 trials |
| 23 | Patrick OttDana-Farber Cancer Institute, MA | 6 trials |
| 24 | David MinorCA | 5 trials |
| 25 | Jeffrey SosmanNorthwestern University Feinberg School of Medicine, IL | 5 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 83 of the 458 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Jedd WolchokWeill Cornell Medicine, NY | 208,418 citations |
| 2 | Frank HodiDana-Farber Cancer Institute, MA | 163,663 citations |
| 3 | Jeffrey SosmanNorthwestern University Feinberg School of Medicine, IL | 129,175 citations |
| 4 | Razelle KurzrockMedical College of Wisconsin, WI | 88,610 citations |
| 5 | Omid HamidThe Angeles Clinic and Research Institute, CA | 85,183 citations |
| 6 | Patrick HwuFL | 76,461 citations |
| 7 | Mario SznolUniversity of Miami Miller School of Medicine, FL | 69,239 citations |
| 8 | Walter UrbaProvidence Portland Medical Center, OR | 62,030 citations |
| 9 | John HainsworthSarah Cannon Research Institute, TN | 58,030 citations |
| 10 | Francesco MarincolaMD | 56,744 citations |
| 11 | Igor PuzanovRoswell Park Comprehensive Cancer Center, NY | 56,731 citations |
| 12 | Elizabeth BuchbinderDana-Farber Cancer Institute, MA | 55,819 citations |
| 13 | Adil DaudUniversity of California, San Francisco, FL | 48,936 citations |
| 14 | David HongThe University of Texas MD Anderson Cancer Center, TX | 47,734 citations |
| 15 | Gerald LinetteMO | 42,222 citations |
| 16 | Ravi AmaravadiUniversity of Pennsylvania, PA | 41,997 citations |
| 17 | Patrick OttDana-Farber Cancer Institute, MA | 41,494 citations |
| 18 | Richard CarvajalNorthwell Health, NY | 39,493 citations |
| 19 | John GlaspyUniversity of California, Los Angeles, CA | 38,724 citations |
| 20 | Kim MargolinSaint John's Cancer Institute, CA | 35,896 citations |
| 21 | Patricia LorussoYale School of Medicine, MI | 34,992 citations |
| 22 | Harriet KlugerYale School of Medicine, CT | 32,554 citations |
| 23 | Alberto PappoSt. Jude Children's Research Hospital, TN | 31,860 citations |
| 24 | Jeffrey InfanteTN | 31,614 citations |
| 25 | Udai KammulaUniversity of Pittsburgh, PA | 30,725 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 62 of the 458 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | William CarsonThe Ohio State University, OH | 19 awards |
| 2 | Thomas GajewskiUniversity of Chicago, IL | 15 awards |
| 3 | Craig SlingluffUniversity of Virginia School of Medicine, VA | 15 awards |
| 4 | Ryan FieldsMO | 14 awards |
| 5 | Paul SondelUniversity of Wisconsin–Madison, WI | 13 awards |
| 6 | Evanthia GalanisMayo Clinic, MN | 13 awards |
| 7 | Jeffrey TraversWright State University Boonshoft School of Medicine, OH | 11 awards |
| 8 | Harriet KlugerYale School of Medicine, CT | 11 awards |
| 9 | James EconomouCA | 9 awards |
| 10 | Frank HodiDana-Farber Cancer Institute, MA | 9 awards |
| 11 | Ravi AmaravadiUniversity of Pennsylvania, PA | 9 awards |
| 12 | Cassian YeeThe University of Texas MD Anderson Cancer Center, TX | 8 awards |
| 13 | Jedd WolchokWeill Cornell Medicine, NY | 7 awards |
| 14 | David AviganDana-Farber Cancer Institute, MA | 7 awards |
| 15 | Walter UrbaProvidence Portland Medical Center, OR | 5 awards |
| 16 | Mark AlbertiniUniversity of Wisconsin–Madison, WI | 5 awards |
| 17 | John GlaspyUniversity of California, Los Angeles, CA | 5 awards |
| 18 | Svetomir MarkovicMayo Clinic, MN | 5 awards |
| 19 | Timothy KuzelNorthwestern University Feinberg School of Medicine, IL | 5 awards |
| 20 | Claire VerschraegenThe Ohio State University, OH | 5 awards |
| 21 | Michael DaviesTX | 4 awards |
| 22 | Kim KramerMemorial Sloan Kettering Cancer Center, NY | 4 awards |
| 23 | Jeffrey SosmanNorthwestern University Feinberg School of Medicine, IL | 4 awards |
| 24 | David HongThe University of Texas MD Anderson Cancer Center, TX | 4 awards |
| 25 | Brendan CurtiProvidence Cancer Institute, OR | 4 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 40 of the 458 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Patricia LorussoYale School of Medicine, MI | 272 contributions |
| 2 | James GulleyNational Cancer Institute, MD | 255 contributions |
| 3 | Siqing FuThe University of Texas MD Anderson Cancer Center, TX | 241 contributions |
| 4 | Omid HamidThe Angeles Clinic and Research Institute, CA | 233 contributions |
| 5 | Jedd WolchokWeill Cornell Medicine, NY | 228 contributions |
| 6 | Frank HodiDana-Farber Cancer Institute, MA | 219 contributions |
| 7 | John HainsworthSarah Cannon Research Institute, TN | 194 contributions |
| 8 | Ahmad TarhiniMoffitt Cancer Center, PA | 174 contributions |
| 9 | Jason LukeStrand Therapeutics, PA | 154 contributions |
| 10 | Igor PuzanovRoswell Park Comprehensive Cancer Center, NY | 139 contributions |
| 11 | Minal BarveMary Crowley Cancer Research, TX | 139 contributions |
| 12 | Adil DaudUniversity of California, San Francisco, FL | 137 contributions |
| 13 | Nikhil KhushalaniMoffitt Cancer Center, NY | 115 contributions |
| 14 | Glenn LesserWake Forest University School of Medicine, NC | 106 contributions |
| 15 | Janice MehnertNYU Langone Health, NY | 103 contributions |
| 16 | Harriet KlugerYale School of Medicine, CT | 103 contributions |
| 17 | Elizabeth BuchbinderDana-Farber Cancer Institute, MA | 98 contributions |
| 18 | Patrick OttDana-Farber Cancer Institute, MA | 97 contributions |
| 19 | Svetomir MarkovicMayo Clinic, MN | 96 contributions |
| 20 | Claire VerschraegenThe Ohio State University, OH | 90 contributions |
| 21 | Mario SznolUniversity of Miami Miller School of Medicine, FL | 88 contributions |
| 22 | John GlaspyUniversity of California, Los Angeles, CA | 81 contributions |
| 23 | Alberto PappoSt. Jude Children's Research Hospital, TN | 78 contributions |
| 24 | David AviganDana-Farber Cancer Institute, MA | 74 contributions |
| 25 | Roxana DroncaMayo Clinic, FL | 70 contributions |
Emerging
25 of the 458 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Neena AgrawalVanderbilt University Medical Center, TN |
| Mark AlbertiniUniversity of Wisconsin–Madison, WI |
| Ana AparicioThe University of Texas MD Anderson Cancer Center, TX |
| Steven BalkBeth Israel Deaconess Medical Center, MA |
| Joshua BurshteinUniversity of Illinois Chicago, IL |
| Stephane ChampiatThe University of Texas MD Anderson Cancer Center, TX |
| David CotterUniversity of Nevada, NV |
| Lindy DavisAlbany Medical Center Hospital, NY |
| David ElpernMA |
| Stephen GruberCity of Hope, CA |
| Matthew HadfieldBrown University, RI |
| Udai KammulaUniversity of Pittsburgh, PA |
| Evan LipsonJohns Hopkins University School of Medicine, MD |
| Joshua MammenUniversity of Nebraska Medical Center, NE |
| Tara McCannelUniversity of California, Los Angeles, CA |
| Wells MessersmithUniversity of Colorado Cancer Center, CO |
| Bilal OmerBaylor College of Medicine, TX |
| Lori PaiTufts Medical Center, MA |
| Alberto PappoSt. Jude Children's Research Hospital, TN |
| Emily RuizBrigham and Women's Hospital, MA |
| Andreas SaltosMoffitt Cancer Center, FL |
| Divya SrivastavaTX |
| Michelle TarboxTexas Tech University, TX |
| Apostolia TsimberidouThe University of Texas MD Anderson Cancer Center, TX |
| Allison VidimosCleveland Clinic, OH |
How these tables are computed
The cohort is every profile in the directory tagged to Melanoma, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Melanoma profile in the directory